- Home
- PMTS vs ENGN Comparison
PMTS vs ENGN Comparison
Compare PMTS & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMTS
- ENGN
- Stock Information
- Founded
- PMTS 2007
- ENGN 1999
- Country
- PMTS United States
- ENGN Canada
- Employees
- PMTS N/A
- ENGN N/A
- Industry
- PMTS Finance Companies
- ENGN
- Sector
- PMTS Finance
- ENGN
- Exchange
- PMTS Nasdaq
- ENGN Nasdaq
- Market Cap
- PMTS 316.9M
- ENGN 297.7M
- IPO Year
- PMTS 2015
- ENGN N/A
- Fundamental
- Price
- PMTS $29.86
- ENGN $4.70
- Analyst Decision
- PMTS Strong Buy
- ENGN Buy
- Analyst Count
- PMTS 4
- ENGN 9
- Target Price
- PMTS $37.25
- ENGN $25.22
- AVG Volume (30 Days)
- PMTS 36.7K
- ENGN 26.8K
- Earning Date
- PMTS 03-04-2025
- ENGN 03-10-2025
- Dividend Yield
- PMTS N/A
- ENGN N/A
- EPS Growth
- PMTS N/A
- ENGN N/A
- EPS
- PMTS 1.64
- ENGN N/A
- Revenue
- PMTS $480,601,000.00
- ENGN N/A
- Revenue This Year
- PMTS $8.62
- ENGN N/A
- Revenue Next Year
- PMTS $7.15
- ENGN N/A
- P/E Ratio
- PMTS $18.09
- ENGN N/A
- Revenue Growth
- PMTS 8.11
- ENGN N/A
- 52 Week Low
- PMTS $16.08
- ENGN $4.20
- 52 Week High
- PMTS $35.19
- ENGN $18.16
- Technical
- Relative Strength Index (RSI)
- PMTS 53.55
- ENGN 40.06
- Support Level
- PMTS $28.25
- ENGN $4.59
- Resistance Level
- PMTS $29.69
- ENGN $5.50
- Average True Range (ATR)
- PMTS 1.49
- ENGN 0.51
- MACD
- PMTS 0.14
- ENGN 0.00
- Stochastic Oscillator
- PMTS 61.36
- ENGN 33.33
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.